Elite Pharmaceuticals Inc (ELTP)

[Drugdoctor]

Ya-don't-say???-Trial-record-1 of-66-for:-eli-200

Experimental: Oxycodone/Naltrexone
Oxycodone/Naltrexone Capsules (over-encapsulated), on days 6-10, every 6 hours (at 09:00, 15:00, 21:00)

Purpose
This single-center study is a randomized, double-blind, active-controlled, multiple-dose, parallel group study to evaluate the potential withdrawal effects, safety and tolerability, and pharmacokinetic and pharmacodynamic effects of multiple doses of oral intact Oxycodone/Naltrexone capsules compared to oxycodone in methadone-maintained opioid-dependent subjects. The study will consist of a Screening Phase, an inpatient Treatment Phase (including a methadone stabilization period, a placebo administration period, a treatment administration period and a safety/washout period), and a Follow-up Phase.


Locations
United States, Kansas
Vince and Associates Recruiting
Overland Park, Kansas, United States, 66212
Contact: Shawnna Blitz 913-696-1601
Principal Investigator: Debra Kelsh, MD
Sub-Investigator: Brad Vince, DO

Contacts
Contact: Chris Dick 201-367-7860 [e-mail]
Contact: Cynthia Phurrough 513-618-0337 [e-mail]


https://www.clinicaltrials.gov/ct2/show/NCT02391571?term=eli-200&rank=1